DiGeorge Syndrome clinical trials

The registry lists 47 studies for DiGeorge Syndrome across more than 10 countries. 11 are recruiting or about to start. 32 of them are mainly about DiGeorge Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27.

Get an email when these change. Save the DiGeorge Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 24
Recruiting: 10
Terminated: 8
Status unknown: 4
Enrolling by invitation: 1

Phase

Phase 2: 9
Phase 1: 5
Phase 4: 1
Phase 3: 1

Where

United States: 30
France: 5
Netherlands: 3
Canada: 2
Australia: 2
Switzerland: 2

Who runs them

Sumitomo Pharma Switzerland GmbH (8) · Hôpital le Vinatier (4) · UMC Utrecht (2) · State University of New York - Upstate Medical University (2) · University of Geneva, Switzerland (2) · National Center for Research Resources (NCRR) (2) · Children's Healthcare of Atlanta (2) · Progenity, Inc. (2)

What is being tested here

Drugs under test in DiGeorge Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	All
Methylphenidate	1	2
Risperidone	1	2
Sertraline	1	1
Fluoxetine	1	1
ZYN002	0	1
Nb-001	0	1
Daclizumab	0	1
Mycophenolic Acid	0	1
Fasoracetam	0	1
Alpha-Methyltyrosine	0	1

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Aug 2027The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome · The Chaim Sheba Medical Center
Sep 2027Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders · Holland Bloorview Kids Rehabilitation Hospital

Who these studies take

Of the 10 DiGeorge Syndrome studies recruiting now, 4 (40%) set no upper age limit and 6 (60%) stop at 75 or younger. 9 (90%) take children under 18. 1 (10%) are for women only and 0 (0%) for men only; 1 (10%) take healthy volunteers.

Recruiting studies that take each age, of 10
Age	Women	Men
10	9 (90%)	8 (80%)
18	6 (60%)	5 (50%)
30	5 (50%)	4 (40%)
40	5 (50%)	4 (40%)
50	4 (40%)	3 (30%)
65	4 (40%)	3 (30%)
75	4 (40%)	3 (30%)
85	4 (40%)	3 (30%)

Across all 47 studies, recruiting or not: 66% stop at 75 or younger and 64% at 65; 81% take children; 9% are for women only and 2% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Results posted1

Immune Disorder HSCT ProtocolOct 27, 2026NCT01821781

Studies

Recruiting first, then most recently updated. Showing 47 of 47. search them.